Nu Skin Enterprises, Inc. (NUS) Stake Lowered by Barings LLC

Share on StockTwits

Barings LLC lessened its holdings in Nu Skin Enterprises, Inc. (NYSE:NUS) by 15.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,130 shares of the company’s stock after selling 3,800 shares during the period. Barings LLC’s holdings in Nu Skin Enterprises were worth $1,742,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Global X Management Co LLC boosted its position in shares of Nu Skin Enterprises by 141.9% in the second quarter. Global X Management Co LLC now owns 1,732 shares of the company’s stock worth $135,000 after buying an additional 1,016 shares during the period. First Hawaiian Bank acquired a new stake in shares of Nu Skin Enterprises in the third quarter worth $165,000. Oppenheimer Asset Management Inc. acquired a new stake in shares of Nu Skin Enterprises in the second quarter worth $210,000. Greenleaf Trust acquired a new stake in shares of Nu Skin Enterprises in the second quarter worth $216,000. Finally, Stevens Capital Management LP acquired a new stake in shares of Nu Skin Enterprises in the second quarter worth $221,000. 76.13% of the stock is owned by institutional investors and hedge funds.

Shares of NYSE:NUS opened at $70.22 on Thursday. The company has a quick ratio of 1.19, a current ratio of 1.82 and a debt-to-equity ratio of 0.46. Nu Skin Enterprises, Inc. has a 1 year low of $59.31 and a 1 year high of $88.68. The firm has a market cap of $3.76 billion, a P/E ratio of 21.70, a PEG ratio of 1.65 and a beta of 1.06.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, August 2nd. The company reported $1.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.90 by $0.18. Nu Skin Enterprises had a return on equity of 25.67% and a net margin of 5.74%. The business had revenue of $704.19 million during the quarter, compared to analyst estimates of $642.16 million. During the same period last year, the company earned $0.77 earnings per share. Nu Skin Enterprises’s quarterly revenue was up 28.0% compared to the same quarter last year. Analysts anticipate that Nu Skin Enterprises, Inc. will post 3.59 earnings per share for the current year.

In related news, General Counsel D Matthew Dorny sold 2,500 shares of the stock in a transaction on Tuesday, September 4th. The stock was sold at an average price of $79.90, for a total transaction of $199,750.00. Following the completion of the sale, the general counsel now directly owns 33,871 shares in the company, valued at $2,706,292.90. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Edwina D. Woodbury sold 5,000 shares of the stock in a transaction on Monday, August 6th. The stock was sold at an average price of $85.02, for a total value of $425,100.00. Following the sale, the director now owns 11,860 shares of the company’s stock, valued at $1,008,337.20. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 42,850 shares of company stock valued at $3,523,563. 3.00% of the stock is owned by corporate insiders.

Several brokerages have recently commented on NUS. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research report on Tuesday, October 23rd. DA Davidson started coverage on Nu Skin Enterprises in a research report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 target price for the company. Jefferies Financial Group reiterated a “buy” rating and set a $98.00 price objective on shares of Nu Skin Enterprises in a report on Tuesday, September 4th. Finally, Stifel Nicolaus upgraded Nu Skin Enterprises from a “sell” rating to a “hold” rating and increased their price objective for the stock from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $86.29.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.

Further Reading: Intrinsic Value and Stock Selection

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply